Next, we investigated the direct effect of Nutlin‐3, an anti‐cancer agent previously shown to disrupt the association between MDM2 and the tumor suppressor p53 (Lievens et al, 2014), on the NL‐MDM2 and PA‐mCit‐p53 interaction. This evidence concerns the gene TP53 and cancer.